HeparinsManufacturerdescribesitspharmacologicaleffectsPharmacologicaleffectsofenoxaparinsodium:thisdrugisapreparationoflowmolecularweightheparin,whichcanmaketheratioofanticoagulantfactorⅹAtoⅱAactivi
1.Intosalt.Weighthecrudeheparinsodium30ganddissolveitinappropriatepurifiedwatertogettheheparinsodiumsolution;Benzethoniumchloride75gwasweighedanddissolvedinpurifiedwatertoobtainbenzethoniumchloridesol
1.Unstableanginapectorisandnon-STsegmentelevationmyocardialinfarction:subcutaneousinjection120U/kg(maximumdose10000U),twiceaday,continuefor5-8daysoruntiltheconditionisstable,andtakeaspirinatthesametim
1.APTTTheHeparinsManufacturerdescribesAPTTasstilloneoftheoptionsformonitoringUFH.Itisverysimple,fastandcheapproject.However,itisdifficulttostandardize.TheAPTTtestrequiresthatallproteinsintheentireclot
1,performancedifferencesLowmolecularweightheparinisakindoflowmolecularweightheparinpreparedbydepolymerizationofgeneralheparin.Itspharmacodynamicsandpharmacokineticcharacteristicsaredifferentfromthoseo